SALPIX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Salpix, and what generic alternatives are available?
Salpix is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in SALPIX is acetrizoate sodium. Additional details are available on the acetrizoate sodium profile page.
Summary for SALPIX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Patent Applications: | 84 |
Formulation / Manufacturing: | see details |
DailyMed Link: | SALPIX at DailyMed |
US Patents and Regulatory Information for SALPIX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ortho Mcneil Pharm | SALPIX | acetrizoate sodium | SOLUTION;INTRAUTERINE | 009008-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |